Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-21-012424

Options or other derivatives

  • President & CEO acquired 330,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Quinn Anthony G. · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-17 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +330,000 330,000 D
Loading xslF345X03/doc4.xml…